Risk factors for complications of therapeutic ERCP: A single center prospective study

Yıl 2006, Cilt: 5 Sayı: 3, 163 - 168, 01.12.2006

Ülkü Sarıtaş İbrahim Gören Altuğ Şenol

Öz

Other than pancreatitis, diagnostic and therapeutic endoscopic retrograde cholangiopancreatography (ERCP) can result in several complications - primarily cholangitis, bleeding, perforation and cardio-respiratory side effects. In this study, we investigated complications of therapeutic ERCP and the risk factors associated with these complications. We did a retrospective study on 100 patients who had undergone ERCP procedure by the same endoscopist and evaluated data regarding clinical and laboratory parameters obtained pre-, during and soon after the ERCP procedure. ERCP could not be done in two patients because of previous gastric operation and Billroth II type gastrojejunostomy and in another two patients who had obstructing duodenum tumor which prevented reaching the papilla. We did selective choledochal cannulation in 86 of 96 patients; nine cases had undergone precut sphincterotomy before selective cannulation, and in one case, percutaneous and endoscopic combined method had been used to cannulate the common bile duct. Totally, seven (7.29%) complications in five patients (5.2%) were observed as follows: one patient had pancreatitis, cholangitis and bleeding; one had cholangitis; one had pancreatitis and bleeding and two had bleeding. There was no mortality, though mild and moderate procedure-related morbidities were noted. All the patients who developed complications were female and two had had residual common bile duct stone. The female gender and residual bile duct stone were determined to be the main risk factors in therapeutic ERCP. After sphincterotomy and cleaning of the common bile duct, the cholangiographic images can miss small stones due to contrast material, and during the first 24 hours, the Oddi edema can prevent spontaneous passage of the residual stone. Thus, as was seen in one of our patients, pancreatitis, cholangitis and bleeding can develop in these cases. Thus, patients should be checked with scopes and in the case of a residual stone, extraction should be completed without delay rather than waiting for spontaneous release. In conclusion, specific patient- and procedure- related factors, including operator experience, can increase the risk of ERCP-related complications. Precise identification of risk factors for complications of ERCP is essential to recognize high-risk cases in which ERCP should be avoided if possible. Furthermore, use of noninvasive imaging modalities instead of diagnostic ERCP and performance of ERCP by an experienced endoscopist will decrease ERCP-related complications.

Anahtar Kelimeler

ERCP, pancreatitis, perforation, cholangitis

Terapotik ERCP komplikasyonları için risk faktörleri: Tek merkezli prospektif çalışma

Öz

Tanı ve tedavi amaçlı ERCP'nin pankreatit başta olmak üzere kolanjit, kanama, perforasyon ve kardiyorespiratuvar komplikasyonları vardır. Bu çalışmanın amacı tedavi amaçlı ERCP komplikasyonları ve bunlar üzerine etkili risk faktörlerini belirlemektir. Bu amaçla tek merkezde aynı endoskopist tarafından gerçekleştirilen ardışık 100 ERCP işleminde, işleme bağlı erken komplikasyonların sayı ve şiddeti ile işlem öncesi, sırası ve sonrasında kaydedilen çok sayıda klinik ve laboratuvar parametrenin değerlendirildiği prospektif bir çalışma planlandı. Yüz hastadan ikisinde daha önce geçirilmiş mide operasyonu ve Bilroth-II tipi gastrojejunostomi ve 2 hastada duodenum tümörü nedeniyle papile ulaşılamadığından ERCP yapılamadı. Geriye kalan 96 hastadan 86 sında selektif koledok kanulasyonu, 9 hastada ön kesiyi takiben koledok kanulasyonu ve 1 hastada perkütan-endoskopik kombine girişim ile koledok kanulasyonunu takiben terapotik ERCP gerçekleştirildi. Bir hastada pankreatit, kolanjit ve kanama, 1 hastada kolanjit, 1 hastada pankreatit ve 2 hastada kanama olmak üzere toplam 5 (%5.2) hastada 7 (%7.29) komplikasyon görüldü. Komplikasyonlar hafif ve orta şiddette olup mortalite yoktu. Komplikasyon gelişen hastaların hepsi kadındı ve ikisinde kalıntı koledok taşı vardı. Kadın cinsiyet ve kalıntı koledok taşı terapotik ERCP komplikasyonları üzerine etkili risk faktörleri olarak saptandı. Koledok taşında EST yi takiben koledok temizliği yapıldıktan sonra opak madde verilerek kontrol kolanjiografi çekildiğinde opak örtmesine bağlı küçük taşlar gözden kaçabilir ve ilk 24 satte oddideki ödeme bağlı spontan düşüş olamayacağından bizim 1 hastamızda olduğu gibi pankreatit, kolanjit ve kanamaya neden olabilir. Bu nedenle işlem bittikten sonra hastaları sırtüstü çevirip kalıntı koledok taşı açısından skopi ile kontrol yapılmalı ve taş varsa spontan düşüş beklenmeden tekrar duodenoskopla girilerek işlem tamamlanmalıdır. Sonuç olarak endoskopistin deneyimi dahil çok sayıda teknik ve hastayla ilgili faktör ERCP ile ilgili komplikasyon oranını artırmaktadır. Endoskopistin yeterli deneyim kazanması, yüksek riskli hastaların belirlenerek mümkünse ERCP'den vazgeçilmesi veya işlemden kaynaklanan risk faktörlerinin azaltılması ve tanısal ERCP yerine mümkün olduğu kadar invaziv olmayan görüntüleme yöntemlerinin kullanılması ERCP ile ilişkili komplikasyonları azaltacaktır.

Anahtar Kelimeler

ERCP, pankreatit, perforasyon, kolanjit

Kaynakça

• Cheng CL, Sherman S, Watkins JL, Barnett B, et al. Risk Factors for Post-ERCP Pancreatitis: A Prospective Multicenter Study. Am J Gastroenterol 2006; 101: 139-47.
• Freeman ML, DiSario JA, Nelson DB, Fennerty MB, et al. Risk fac- tors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 2001; 54: 425-34.
• Cotton P, Williams C.ERCP and Therapy. Risks and Indications. In: Cotton P, Williams C, editors. Practical Gastrointestyinal Endos- copy. 4thed. Oxford: Blackwell Science; 1996; 186.
• Christensen M, Matzen P, Schulze S, Rosenberg J. Complications of ERCP: a prospective study. Gastrointest Endosc 2004; 60: 721-31.
• Kuran S, Parlak E, Oguz D, Cicek B, et al. Endoscopic sphinctero- tomy induced hemorrhage: treatment with heat probe. Gastrointest Endosc 2006; 63: 506-11.
• Stefanidis G, Karamanolis G, Viazis N, Sgouros S, et al. A compa- rative study of postendoscopic sphincterotomy complications with various types of electrosurgical current in patients with choledocho- lithiasis. Gastrointest Endosc 2003; 57: 192-7.
• Freeman ML, Nelson DB, Sherman S, Haber GB, et al. Complicati- ons of endoscopic biliary sphincterotomy. N Engl J Med 1996; 335: 909-18.
• Vandervoort J, Soetikno RM, Tham TC, Wong RC, et al. Risk factors for complications after performance of ERCP. Gastrointest Endosc 2002; 56: 652-6.
• Gorelick A, Cannon M, Barnett J, Chey W, et al. First cut, then blend: an electrocautery technique affecting bleeding at sphinctero- tomy. Endoscopy 2001; 33: 976-80.
• Elta GH, Barnett JL, Wille RT, Brown KA, et al. Pure cut electroca- utery current for sphincterotomy causes less post-procedure panc- reatitis than blended current. Gastrointest Endosc 1998; 47: 149- 53.
• Macintosh DG, Love J, Abraham NS. Endoscopic sphincterotomy by using pure-cut electrosurgical current and the risk of post-ERCP pancreatitis: a prospective randomized trial. Gastrointest Endosc 2004; 60: 551-6.
• Stefanidis G, Karamanolis G, Viazis N, Sgouros S, et al. A compa- rative study of postendoscopic sphincterotomy complications with various types of electrosurgical current in patients with choledocho- lithiasis. Gastrointest Endosc 2003; 57: 192-7.
• Masci E, Toti G, Mariani A, Curioni S , et al. Complications of di- agnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 2001; 96: 417-23.
• Sarıtaş Ü, Parlak E . Risc faktors for post ERCP pancreatitis: A prospective studies. Endoscopy 2000; 32: 48.
• Frank CD, Adler DG. Post-ERCP pancreatitis and its prevention. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 680.
• Pande H, Thuluvath P. Pharmacological prevention of post-endos- copic retrograde cholangiopancreatography pancreatitis. Drugs 2003; 63: 1799-812.
• Rabenstein T, Fischer B, Wiessner V, Schmidt H, et al. Low-molecu- lar-weight heparin does not prevent acute post-ERCP pancreatitis. Gastrointest Endosc 2004; 59: 606-13.
• Li Z, S , Pan X, , Zhang WJ., Gong B, et al. Effect of Octreotide Ad- ministration in the Prophylaxis of Post-ERCP Pancreatitis and Hyperamylasemia: A Multicenter, Placebo-Controlled, Randomized Clinical Trial. Am J Gastroneterol 2007; 102: 46-51.
• Sternlieb JM, Aronchick CA, Retig JN, et al. A multicenter, rando- mized, controlled trial to evaluate the effect of prophylactic octreoti- de on ERCP-induced pancreatitis. Am J Gastroenterol 1992; 87: 1561–6.
• Ong TZ, Khor JL, Selamat DS, Yeoh KG, et al. Complications of en- doscopic retrograde cholangiography in the post-MRCP era: a ter- tiary center experience. World J Gastroenterol 2005; 11: 5209-12.